Free Trial

LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular logo
$79.12 -2.38 (-2.92%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$79.19 +0.07 (+0.09%)
As of 05/22/2025 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LMAT vs. STVN, GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, and PRCT

Should you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

LeMaitre Vascular vs.

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking.

LeMaitre Vascular received 484 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%
LeMaitre VascularOutperform Votes
515
70.45%
Underperform Votes
216
29.55%

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.12B6.12$157.62M$0.5144.53
LeMaitre Vascular$226.26M7.90$30.10M$1.9839.96

Stevanato Group has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 9.5% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

LeMaitre Vascular has a net margin of 19.40% compared to Stevanato Group's net margin of 10.47%. LeMaitre Vascular's return on equity of 13.15% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
LeMaitre Vascular 19.40%13.15%11.47%

LeMaitre Vascular has a consensus price target of $98.14, suggesting a potential upside of 24.04%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
LeMaitre Vascular
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.63

In the previous week, LeMaitre Vascular had 1 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for LeMaitre Vascular and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.74 beat LeMaitre Vascular's score of 0.58 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
LeMaitre Vascular
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 1.0%. Stevanato Group pays out 11.8% of its earnings in the form of a dividend. LeMaitre Vascular pays out 40.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stevanato Group has increased its dividend for 1 consecutive years and LeMaitre Vascular has increased its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

LeMaitre Vascular beats Stevanato Group on 14 of the 21 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LMAT vs. The Competition

MetricLeMaitre VascularSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.79B$4.43B$5.33B$8.39B
Dividend Yield0.94%43.63%5.21%4.11%
P/E Ratio43.2329.0826.7119.71
Price / Sales7.9066.76386.08120.53
Price / Cash56.5251.0838.2534.62
Price / Book5.916.196.774.50
Net Income$30.10M$67.60M$3.23B$248.22M
7 Day Performance-6.67%-0.63%1.80%0.56%
1 Month Performance-11.64%17.91%11.10%13.17%
1 Year Performance-0.58%21.16%17.11%7.30%

LeMaitre Vascular Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LMAT
LeMaitre Vascular
2.5871 of 5 stars
$79.12
-2.9%
$98.14
+24.0%
-1.1%$1.79B$226.26M43.23490Insider Trade
STVN
Stevanato Group
1.3372 of 5 stars
€23.64
-1.5%
N/A+17.1%$7.16B$1.10B50.304,650Positive News
GKOS
Glaukos
4.615 of 5 stars
$94.57
+5.1%
$134.67
+42.4%
-9.6%$5.40B$404.52M-32.95780Positive News
Analyst Revision
NARI
Inari Medical
0.5748 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
INSP
Inspire Medical Systems
4.6675 of 5 stars
$156.54
+3.5%
$211.91
+35.4%
-9.6%$4.62B$840.11M90.49760Positive News
Gap Up
IRTC
iRhythm Technologies
1.2487 of 5 stars
$137.80
+0.1%
$128.55
-6.7%
+57.2%$4.40B$618.59M-37.861,790Positive News
Analyst Forecast
BLCO
Bausch + Lomb
4.1301 of 5 stars
$11.91
+5.6%
$15.50
+30.2%
-23.3%$4.21B$4.83B-13.0812,500Gap Up
TMDX
TransMedics Group
1.2881 of 5 stars
$118.73
+6.5%
$126.70
+6.7%
-10.0%$4.02B$488.23M126.31210Positive News
Gap Down
SLNO
Soleno Therapeutics
4.8459 of 5 stars
$76.70
-0.1%
$106.78
+39.2%
+72.4%$3.87BN/A-23.1030News Coverage
Positive News
NVST
Envista
4.174 of 5 stars
$18.56
+5.5%
$20.08
+8.2%
-9.6%$3.15B$2.50B-2.8612,700Positive News
Gap Up
PRCT
PROCEPT BioRobotics
2.9119 of 5 stars
$54.44
+2.5%
$90.00
+65.3%
-13.9%$3.01B$249.12M-27.92430Positive News

Related Companies and Tools


This page (NASDAQ:LMAT) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners